Translational Development Acquisition Corp. (TDACW) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2022: -$22.1K2023: -$507.7K2024: -$5.60M2025: -$6.54M-$6.54M
2022Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$6.54M-16.9%
2024-$5.60M-1002.6%
2023-$507.7K-2196.3%
2022-$22.1K